Transdermal Basal Insulin Patch Study in Type 1 Diabetes

NCT00519623 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes

Interventions

OTHER: PassPort(R) Transdermal Insulin Delivery System

Sponsor

Altea Therapeutics